<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Brain</journal-id>
<journal-id journal-id-type="iso-abbrev">Brain</journal-id>
<journal-id journal-id-type="publisher-id">brainj</journal-id>
<journal-title-group>
<journal-title>Brain</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-8950</issn>
<issn pub-type="epub">1460-2156</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30668640</article-id>
<article-id pub-id-type="pmc">6391616</article-id>
<article-id pub-id-type="doi">10.1093/brain/awy354</article-id>
<article-id pub-id-type="publisher-id">awy354</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer’s disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zheng</surname>
<given-names>Yan</given-names>
</name>
<xref ref-type="aff" rid="awy354-aff1">1</xref>
<xref ref-type="aff" rid="awy354-aff2">2</xref>
<xref ref-type="author-notes" rid="awy354-FN1"></xref>
<xref ref-type="corresp" rid="awy354-cor1"></xref>
<!--<email>zhenyan@buffalo.edu</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Aiyi</given-names>
</name>
<xref ref-type="aff" rid="awy354-aff1">1</xref>
<xref ref-type="aff" rid="awy354-aff3">3</xref>
<xref ref-type="author-notes" rid="awy354-FN1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Zi-Jun</given-names>
</name>
<xref ref-type="aff" rid="awy354-aff1">1</xref>
<xref ref-type="aff" rid="awy354-aff4">4</xref>
<xref ref-type="author-notes" rid="awy354-FN1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cao</surname>
<given-names>Qing</given-names>
</name>
<xref ref-type="aff" rid="awy354-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="awy354-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Lin</given-names>
</name>
<xref ref-type="aff" rid="awy354-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ma</surname>
<given-names>Kaijie</given-names>
</name>
<xref ref-type="aff" rid="awy354-aff1">1</xref>
<xref ref-type="aff" rid="awy354-aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Freddy</given-names>
</name>
<xref ref-type="aff" rid="awy354-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wei</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="aff" rid="awy354-aff1">1</xref>
<xref ref-type="aff" rid="awy354-aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Matas</surname>
<given-names>Emmanuel</given-names>
</name>
<xref ref-type="aff" rid="awy354-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cheng</surname>
<given-names>Jia</given-names>
</name>
<xref ref-type="aff" rid="awy354-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Guo-Jun</given-names>
</name>
<xref ref-type="aff" rid="awy354-aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Xiaomin</given-names>
</name>
<xref ref-type="aff" rid="awy354-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yan</surname>
<given-names>Zhen</given-names>
</name>
<xref ref-type="aff" rid="awy354-aff1">1</xref>
<xref ref-type="aff" rid="awy354-aff4">4</xref>
</contrib>
</contrib-group>
<aff id="awy354-aff1"><label>1</label>Department of Physiology and Biophysics, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA</aff>
<aff id="awy354-aff2"><label>2</label>Department of Physiology, Key Laboratory for Neurodegenerative Disorders of the Ministry of Education, Beijing Institute for Brain Disorders, Capital Medical University, Beijing, P.R.China</aff>
<aff id="awy354-aff3"><label>3</label>Department of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing, P.R.China</aff>
<aff id="awy354-aff4"><label>4</label>VA Western New York Healthcare System, Buffalo, NY, USA</aff>
<author-notes>
<corresp id="awy354-cor1">Correspondence to: Zhen Yan Department of Physiology and Biophysics, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA E-mail: <email>zhenyan@buffalo.edu</email></corresp>
<fn id="awy354-FN1">
<p>Yan Zheng, Aiyi Liu and Zi-Jun Wang authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date iso-8601-date="2019-01-22" pub-type="epub">
<day>22</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>3</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>142</volume>
<issue>3</issue>
<fpage>787</fpage>
<lpage>807</lpage>
<history>
<date date-type="received">
<day>4</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>1</day>
<month>11</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>11</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="publisher-standard" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</ext-link>)</license-p>
</license>
</permissions>
<self-uri xlink:href="awy354.pdf"></self-uri>
<abstract abstract-type="teaser">
<p>Zheng <italic>et al.</italic> show that levels of histone methyltransferases EHMT1/2, and of the histone methylation H3K9me2, are elevated in prefrontal cortex of a familial Alzheimer’s disease (FAD) mouse model and human postmortem tissue. Inhibition of EHMT1/2 rescues cognitive deficits by relieving H3K9me2-mediated repression of glutamate receptor transcription in FAD mice.</p>
</abstract>
<abstract>
<title>Abstract</title>
<p>Epigenetic dysregulation, which leads to the alteration of gene expression in the brain, is suggested as one of the key pathophysiological bases of ageing and neurodegeneration. Here we found that, in the late-stage familial Alzheimer’s disease (FAD) mouse model, repressive histone H3 dimethylation at lysine 9 (H3K9me2) and euchromatic histone methyltransferases EHMT1 and EHMT2 were significantly elevated in the prefrontal cortex, a key cognitive region affected in Alzheimer’s disease. Elevated levels of H3K9me2 were also detected in the prefrontal cortex region of post-mortem tissues from human patients with Alzheimer’s disease. Concomitantly, H3K9me2 at glutamate receptors was increased in prefrontal cortex of aged FAD mice, which was linked to the diminished transcription, expression and function of AMPA and NMDA receptors. Treatment of FAD mice with specific EHMT1/2 inhibitors reversed histone hyper-methylation and led to the recovery of glutamate receptor expression and excitatory synaptic function in prefrontal cortex and hippocampus. Chromatin immunoprecipitation-sequencing (ChIP-seq) data indicated that FAD mice exhibited genome-wide increase of H3K9me2 enrichment at genes involved in neuronal signalling (including glutamate receptors), which was reversed by EHMT1/2 inhibition. Moreover, the impaired recognition memory, working memory, and spatial memory in aged FAD mice were rescued by the treatment with EHMT1/2 inhibitors. These results suggest that disrupted epigenetic regulation of glutamate receptor transcription underlies the synaptic and cognitive deficits in Alzheimer’s disease, and targeting histone methylation enzymes may represent a novel therapeutic strategy for this prevalent neurodegenerative disorder.</p>
</abstract>
<kwd-group kwd-group-type="keywords">
<kwd>Alzheimer’s disease</kwd>
<kwd>histone methylation</kwd>
<kwd>epigenetics</kwd>
<kwd>memory</kwd>
<kwd>glutamate receptor</kwd>
</kwd-group>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">VA Merit</named-content>
</funding-source>
<award-id>I01BX001633</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institutes of Health</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
<award-id>R01-AG056060</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Key Research and Development Program of China</named-content>
</funding-source>
<award-id>2016YFC1306300</award-id>
<award-id>81571038</award-id>
<award-id>81771145</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">NSFC</named-content>
<named-content content-type="funder-identifier">10.13039/501100001809</named-content>
</funding-source>
<award-id>81171197</award-id>
<award-id>81220108010</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="21"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>